Regent Investment Management LLC Vertex Pharmaceuticals Inc Transaction History

Regent Investment Management LLC

  • $373 Million
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 19, 2020
SELL
$255.65 - $303.1 $178,955 - $212,170
-700 Closed
0 $0
Q2 2020

Jul 29, 2020
BUY
$225.48 - $295.8 $157,836 - $207,060
700 New
700 $203,000
Q1 2020

Apr 17, 2020
SELL
$199.77 - $247.81 $189,781 - $235,419
-950 Closed
0 $0
Q4 2019

Jan 30, 2020
BUY
$166.71 - $223.91 $158,374 - $212,714
950 New
950 $208,000

Others Institutions Holding VRTX

# of Institutions
1,722
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Regent Investment Management LLC Portfolio

Follow Regent Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regent Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regent Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email